Table 1:

Baseline characteristics of the matched cohorts

CharacteristicNo. (%)* of participants n = 41 251Standardized mean differenceNo. (%)* of participants n = 42 255Standardized mean difference
With sepsisMatched population control cohortWith sepsisMatched hospital control cohort
Male sex24 436 (59.2)24 436 (59.2)024 976 (59.1)24 976 (59.1)0
Age, mean ± SD; yr67.73 ± 17.5967.95 ± 17.73−0.0167.28 ± 17.8366.44 ± 18.430.05
Preadmission comorbidity
Myocardial infarction2437 (5.9)2446 (5.9)−0.00092360 (5.6)1923 (4.5)0.04
Congestive heart failure10 268 (24.9)10 453 (25.3)−0.0110 204 (24.1)7613 (18.0)0.15
Peripheral vascular disease4718 (11.4)5046 (12.2)−0.024722 (11.18)3650 (8.6)0.08
Cerebrovascular disease15 631 (37.9)15 058 (36.5)0.0315 489 (36.7)12 294 (29.1)0.16
Dementia5460 (13.2)5112 (12.4)0.035468 (12.9)3400 (8.05)0.16
Chronic obstructive pulmonary disease22 027 (53.4)22 460 (54.4)−0.0222 248 (52.7)20 900 (49.5)0.06
Rheumatologic disease1721 (4.2)2048 (5.06)−0.041748 (4.1)1455 (3.4)0.03
Peptic ulcer disease20 562 (49.8)21 538 (52.2)−0.0520 646 (48.9)20 281 (48.0)0.01
Mild liver disease16 160 (39.2)16 877 (40.9)−0.0416 191 (38.3)15 107 (35.8)0.05
Moderate or severe liver disease15 495 (37.6)15 210 (36.9)0.0115 523 (36.7)12 797 (30.3)0.13
Diabetes without chronic complications6947 (16.8)6914 (16.8)0.0026947 (16.4)4673 (11.1)0.15
Diabetes with chronic complications4191 (10.2)4384 (10.6)−0.024180 (9.9)2796 (6.6)0.11
Hemiplegia or paraplegia7960 (19.3)8176 (19.8)−0.017908 (18.7)5537 (13.1)0.15
Chronic renal disease8469 (20.5)8060 (19.5)0.028281 (19.6)7611 (18.0)0.04
Leukemia and lymphoma1449 (3.5)1032 (2.5)0.061382 (3.3)1198 (2.8)0.02
Metastatic solid tumour2041 (4.9)2061 (5.0)−0.0021900 (4.5)1989 (4.7)−0.01
AIDS or HIV63 (0.1)63 (0.1)061 (0.1)54 (0.1)0.004
  • Note: SD = standard deviation.

  • * Unless specified otherwise.